Cargando…
p53-PHLDA3-Akt Network: The Key Regulators of Neuroendocrine Tumorigenesis
p53 is a well-known tumor suppressor gene and one of the most extensively studied genes in cancer research. p53 functions largely as a transcription factor and can trigger a variety of antiproliferative programs via induction of its target genes. We identified PHLDA3 as a p53 target gene and found t...
Autores principales: | Chen, Yu, Ohki, Rieko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7312810/ https://www.ncbi.nlm.nih.gov/pubmed/32521808 http://dx.doi.org/10.3390/ijms21114098 |
Ejemplares similares
-
A vicious partnership between AKT and PHLDA3 to facilitate neuroendocrine tumors
por: Takikawa, Masahiro, et al.
Publicado: (2017) -
PHLDA1, another PHLDA family protein that inhibits Akt
por: Chen, Yu, et al.
Publicado: (2018) -
PHLDA2 is a key oncogene-induced negative feedback inhibitor of EGFR/ErbB2 signaling via interference with AKT signaling
por: Wang, Xiaoqi, et al.
Publicado: (2015) -
Pleckstrin homology-like domain family A, member 3 (PHLDA3) deficiency improves islets engraftment through the suppression of hypoxic damage
por: Sakata, Naoaki, et al.
Publicado: (2017) -
TRIM21 and PHLDA3 negatively regulate the crosstalk between the PI3K/AKT pathway and PPP metabolism
por: Cheng, Jie, et al.
Publicado: (2020)